Skip to content
★ Sign in to follow
SY

Stephen Yoo

Executive
Total declarations
43
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (31 ops.)
€7.6M

Latest filing published 06 Dec 2018 for REGENXBIO Inc., €15k.

Filing timeline

BuySale
Stephen Yoo

Insider track record

Disclosed buys
0
Disclosed sells
31
Signal history

Stephen Yoo: trading record in brief

Stephen Yoo discloses dealings in REGENXBIO Inc. to SEC (Form 4). Between 20 June 2017 and 3 December 2018, the trades on record add up to 43 filings.

The open-market record consists of 31 sales worth €7.6M, with no purchase. Besides market trades, the filings include 12 option exercises. Since January 2018: no purchases and 24 sales on the market.

The newest entry dates from 6 December 2018: an open-market sale of €27k, in REGENXBIO Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Stephen Yoo

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations43 total
  • ◇
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    17,352 USD11SEC
    20,414 shares@ US$0.850.3% of flowCommon StockSEC:0001562180-18-004850:0
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    408,635 USD30SEC
    6,854 shares@ US$59.626.4% of flowCommon StockSEC:0001562180-18-004850:1
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    787,749 USD30SEC
    13,053 shares@ US$60.3512.3% of flowCommon StockSEC:0001562180-18-004850:2
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    31,028 USD29SEC
    507 shares@ US$61.200.5% of flowCommon StockSEC:0001562180-18-004850:3
  • ◇
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    17,352 USD11SEC
    20,414 shares@ US$0.850.3% of flowCommon StockSEC:0001562180-18-004642:0
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    157,598 USD29SEC
    2,761 shares@ US$57.082.5% of flowCommon StockSEC:0001562180-18-004642:1
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    134,251 USD29SEC
    2,300 shares@ US$58.372.1% of flowCommon StockSEC:0001562180-18-004642:2
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    541,974 USD30SEC
    9,092 shares@ US$59.618.4% of flowCommon StockSEC:0001562180-18-004642:3
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    262,750 USD29SEC
    4,361 shares@ US$60.254.1% of flowCommon StockSEC:0001562180-18-004642:4
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    49,240 USD29SEC
    800 shares@ US$61.550.8% of flowCommon StockSEC:0001562180-18-004642:5
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    69,531 USD29SEC
    1,100 shares@ US$63.211.1% of flowCommon StockSEC:0001562180-18-004642:6
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    226,145 USD29SEC
    3,413 shares@ US$66.262.6% of flowCommon StockSEC:0001562180-18-004452:1
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    323,615 USD30SEC
    4,820 shares@ US$67.145.0% of flowCommon StockSEC:0001562180-18-004452:2
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    252,414 USD29SEC
    3,700 shares@ US$68.223.9% of flowCommon StockSEC:0001562180-18-004452:3
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    268,007 USD29SEC
    3,854 shares@ US$69.544.2% of flowCommon StockSEC:0001562180-18-004452:4
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    323,751 USD30SEC
    4,627 shares@ US$69.975.0% of flowCommon StockSEC:0001562180-18-004452:5
  • ◇
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    17,352 USD11SEC
    20,414 shares@ US$0.850.3% of flowCommon StockSEC:0001562180-18-004452:0
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    6,442 USD29SEC
    100 shares@ US$64.420.1% of flowCommon StockSEC:0001562180-18-004338:6
  • ◇
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    17,352 USD11SEC
    20,414 shares@ US$0.850.3% of flowCommon StockSEC:0001562180-18-004338:0
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    182,003 USD29SEC
    3,042 shares@ US$59.832.8% of flowCommon StockSEC:0001562180-18-004338:1
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    103,122 USD29SEC
    1,700 shares@ US$60.661.6% of flowCommon StockSEC:0001562180-18-004338:2
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    129,822 USD29SEC
    2,100 shares@ US$61.822.0% of flowCommon StockSEC:0001562180-18-004338:3
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    505,076 USD30SEC
    8,026 shares@ US$62.937.9% of flowCommon StockSEC:0001562180-18-004338:4
  • ▼
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    346,747 USD30SEC
    5,446 shares@ US$63.675.4% of flowCommon StockSEC:0001562180-18-004338:5
  • ◇
    Chief Medical OfficerExecutivesREGENXBIO Inc.
    8,500 USD11SEC
    10,000 shares@ US$0.850.1% of flowCommon StockSEC:0001562180-18-004242:0

25 of 43 declarations